Table 8. Diagnostic value of small intestinal biopsy
_________________________________________________________________________
Disease Histological features
_________________________________________________________________________
Pathognomonic in diffuse disease
- Abetalipoproteinemia Normal villi, lipid vacuoles in enterocytes, no cellular infiltrate
- Agammaglobulinemia/ Villi atrophic or absent, lymphocytic
hypogammaglobulinemia infiltration, few plasma cells, often associated with giardiasis
- Whipple´s disease Villi often irregular, lamina propria contains
PAS-positive macrophages containing the bacilli
- Microvillus inclusion Nearly no microvilli, crypts defective, multiple secretory
disease granules, intracytoplasmatic inclusion bodies are characteristic
- Tufting enteropathy Partial villus atrophy, crypt hyperplasia, no inflammatory cells,
typical focal epithelial tufts consisting of patched enterocytes with
apical round protrusions of plasma membrane
Helpful, but not diagnostic by itself
- AIDS enteropathy Alternating villous atrophy with crypt hyperplasia, mild lymphocytic
infiltrate, often associated parasitosis: Cryptosporidia, Microsporidia,
Giardia lamblia; PAS- positive macrophages in lamina propria,
containing Mycobacterium avium intracellulare
- Amyloidosis Normal mucosa, Congo red-positive deposits in blood vessels and
lamina muscularis mucosae
- Crohn´s disease Mucosal appearance varies from normal to severe ulcerations,
inflammatory infiltrate, granuloma
- Eosinophilic enteritis Villi usually normal, eosinophillic infiltrate in lamina propria
- Giardiasis Mucosa normal or with various degrees of atrophy;
varying inflammation in lamina propria; sickle-shaped
organisms on the epithelial surface
- Intestinal Deformed villi, dilated lymphatics
lymphangiectasia
- Intestinal lymphoma Infiltration of submucosa and lamina propria with malignant
lymphocytes; often also villous atrophy
- Mastocytosis Villi normal or atrophic; lamina propria infiltrated with mast cells,
eosinophils and neutrophils
Abnormal, but not diagnostic
- Celiac disease Villi atrophic or absent; hyperplastic & elongated crypts; chronic
inflammatory infiltrate in lamina propria; epithelial surface infiltrated
with lymphocytes
- Autoimmune enteropathy Like in celiac disease, but no AMA & EMA antibodies
- Collagenous sprue Subepithelial collagen deposits; villous atrophy of various degree
- Tropical sprue Villous atrophy; epithelial damage and degree of atrophy less severe
than in celiac disease
- Vitamin B12 & folic Short villi, damaged epithelial cells, decreased
acid deficiency mitosis rate in crypts; megaloblastic crypt cells
- Bacterial overgrowth Villi may be damaged; crypt hyperplasia; chronic inflammation of
lamina propria
- Radiation enteritis Acute lesions: deformed villi and megaloblastic crypt cells with
reduced mitosis rate. Chronic lesions: fibroblasts and intimal cells
proliferation of blood vessels
- Drugs (colchicin, Shortened villi, abnormal epithelial cells
neomycin, cytostatics)
_________________________________________________________________________
Table 9. Diseases resulting in malabsorption syndrome
____________________________________________________________________
Maldigestion due to deficiency or inactivation of pancreatic enzymes
· Chronic pancreatitis
· Surgical resection of the pancreas
· Pancreatic cancer
· Cystic fibrosis
· Zollinger-Ellison syndrome
Maldigestion due to impaired luminal bile acid concentration
· Obstructive jaundice
· Intrahepatic cholestasis
· Primary biliary cirrhosis
· Primary sclerosing cholangitis
· Small intestinal bacterial overgrowth (blind loop syndrome, fistulas, strictures, diverticula, afferent loop syndrome, motility disorders in scleroderma and diabetic gastroenteropathy)
· Ileal resection (decompensated bile acid loss)
· Crohn´s disease of the ileum
Maldigestion/malabsorption due to small intestinal diseases
1. Primary malabsorption: congenital diseases with selective defect of single functions of epithelial cells (disorders of the brush border membrane)
· Lactose intolerance
· Sucrose-isomaltose intolerance
· Trehalose intolerance
· Enterokinase deficiency
· Glucose-galactose intolerance
· Hartnup´s disease
· Cystinuria
· Tryptophan malabsorption (“blue diaper disease”)
· Methionine malabsorption (Oasthouse syndrome)
· Vitamin B12 malabsorption (congenital defect of intrinsic factor or vitamin B12 receptor)
· Microvillus inclusion disease
· Tufting enteropathy
2. Secondary malabsorption: acquired small intestinal diseases
· Celiac disease
· Autoimmune enteropathy
· Dermatitis herpetiformis
· Tropical sprue
· Whipple´s disease
· Primary intestinal lymphoma
· Hypogammaglobulinemia
· Selective IgA deficiency
· Eosinophilic gastroenteritis
· Mastocytosis
· Amyloidosis
· Parasitoses (giardiasis, strongyloidosis, ascaridosis, ancylostomiasis)
· HIV enteropathy with wasting syndrome
· Tuberculosis
· Lymphogranulomatosis
· Kwashiorkor
· Short bowel syndrome
· Intestinal ischemia
· Radiation enteritis
Various disorders of digestion and absorption
· Postgastrectomy syndrome
· Postvagotomy syndrome
· Diabetic gastroenteropathy
· Endocrinopathies (hyper- and hypothyroidism, hyper- and hypoparathyroidism, Addison´s
disease, medullary carcinoma of the thyroid)
· Glucagonoma, gastrinoma, VIPoma
· Scleroderma
· Pernicious anemia
Drug-induced malabsorption
· Cholestyramine
· Laxatives
· Colchicin
· Antineoplastic drugs
· Neomycin
· p-aminosalicylic acid (PAS)
· Biguanides
· Acarbose and miglitol
· Lactulose, sorbitol, fructose
· Non-steroidal antiinflammatory drugs (NSAID)
· Alcohol
____________________________________________________________________
Table 10. Lactase deficiency - ethnic differences
(modified from reference [5])
____________________________________________________________________
Population Incidence (%)
____________________________________________________________________
Northern European 5-15
Mediterranean 60-85
African 85-100
America (African-American) 45-80
America (Caucasian) 10-25
American Indian 50-95
Hispanic 40-75
Asian 90-100
____________________________________________________________________
Table 11. Carbohydrate malabsorption
____________________________________________________________________
Malabsorption of Disease
____________________________________________________________________
Starch Congenital alpha-amylase deficiency not known
Secondary alpha-amylase deficiency in exocrine
pancreatic insufficiency
“Physiological” starch malabsorption
Therapy with alpha-glucosidase inhibitors
(acarbose)
Lactose Congenital lactase deficiency
Transient lactase deficiency in premature infants
Acquired lactase deficiency
Secondary lactase deficiency in small intestinal
disease
Trehalose Congenital trehalase deficiency
Secondary trehalase deficiency in small
intestinal disease
Sucrose Congenital sucrase-isomaltase deficiency
Secondary sucrase-isomaltase deficiency in small intestinal disease
Therapy with alpha-glucosidase inhibitors
Maltose, maltotriose Congenital maltase deficiency not known
Alpha-maltodextrins Secondary maltase deficiency in small intestinal disease
Therapy with alpha-glucosidase inhibitors
Glucose, galactose Congenital glucose-galactose malabsorption
Secondary malabsorption of glucose and galactose
in small intestinal disease, bacterial
overgrowth, or intestinal hypermotility
Fructose Congenital transport defect not known
“Physiological” malabsorption if > 30-50 g/day
are ingested
Secondary malabsorption of fructose in small
intestinal disease, bacterial overgrowth, or
intestinal hypermotility
D-xylose Congenital transport defect not known
Secondary malabsorption in small intestinal
disease, bacterial overgrowth, or intestinal
hypermotility
____________________________________________________________________